Maravai Lifesciences Holdings Inc
General ticker "MRVI" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $1.5B
Maravai Lifesciences Holdings Inc does not follow the US Stock Market performance with the rate: -2.0%.
Estimated limits based on current volatility of 3.0%: low 5.21$, high 5.53$
Factors to consider:
- North America accounted for 48.8% of revenue in the fiscal year ended 2023-12-31
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [3.56$, 8.31$]
- 2024-12-30 to 2025-12-30 estimated range: [4.05$, 8.57$]
Financial Metrics affecting the MRVI estimates:
- Negative: Non-GAAP EPS, $ of -0.03 <= 0.10
- Negative: Operating profit margin, % of -9.87 <= 1.03
- Negative: negative Net income
- Positive: Operating cash flow per share per price, % of 16.69 > 12.76
- Positive: -0.96 < Investing cash flow per share, $ of -0.93
- Negative: Industry operating profit margin (median), % of -12.70 <= 2.14
- Negative: Inventory ratio change, % of 9.91 > 1.08
Short-term MRVI quotes
Long-term MRVI plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $810.49MM | $883.00MM | $288.94MM |
| Operating Expenses | $255.84MM | $308.79MM | $320.59MM |
| Operating Income | $554.64MM | $574.22MM | $-31.65MM |
| Non-Operating Income | $-23.88MM | $-22.74MM | $649.38MM |
| Interest Expense | $30.26MM | $20.41MM | $45.89MM |
| R&D Expense | $15.22MM | $18.37MM | $17.28MM |
| Income(Loss) | $530.76MM | $551.47MM | $617.74MM |
| Taxes | $61.52MM | $60.81MM | $756.11MM |
| Profit(Loss) | $469.25MM | $490.66MM | $-138.38MM |
| Stockholders Equity | $315.50MM | $545.22MM | $416.75MM |
| Inventory | $51.56MM | $43.15MM | $51.40MM |
| Assets | $1,918.28MM | $2,282.32MM | $1,487.45MM |
| Operating Cash Flow | $368.57MM | $535.98MM | $126.22MM |
| Capital expenditure | $14.85MM | $17.09MM | $65.55MM |
| Investing Cash Flow | $105.66MM | $-267.61MM | $-122.31MM |
| Financing Cash Flow | $-159.05MM | $-187.50MM | $-61.09MM |
| Earnings Per Share* | $4.09 | $3.73 | $-0.90 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.